Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical Technologies of Georgia manufactures and markets intermittent urinary catheters, including closed-system and specialty designs for adults and children with mobility or hand-dexterity impairments; products are marketed commercially and incorporated into HR Pharmaceuticals’ broader urology portfolio after MTG’s acquisition in 2022.[1][2][4]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Technologies of Georgia.